The effects of oral L-carnitine treatment on blood lipid metabolism and the body fat content in the diabetic patient

Asia Pacific Journal of Clinical Nutrition

Volumn 7, Issue 2, 1998, Pages 192-195

  Liang, Yiquan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Carnitine; Fat distribution; Non insulin dependent diabetes mellitus; Percentage of body fat; Triglycerides

Indexed keywords

EID: 24044475940     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Maebashi M, Kawamura N, Sato M et al. Lipid-lowering effect of camitine in patients with type-IV hyperlipoproteinemia. Lancet 1978; 2: 805.
2. Pepine CJ. The therapeutic potential of carnitine in cardiovascular disorders. Clin Ther 1991; 13: 2.
3. Paulson DJ, Schmidt MJ, Traxler TS et al. Improvement of myocardial function in diabetic rats after treatment with L-carnitine. Metabolism 1984; 33: 358.
4. Wang J, Heymsfield SB, Aulet M et al. Body fat from body density: underwater weighing vs dual-photon absorptiometry. Am J Physiol 1989; 256: E829.
5. Nord RH, Payne RK. Body composition by dual-energy X-ray absorptiometry: a review of the technology. Asia Pacific J Clin Nutr 1995; 4: 167.
6. Beck-Nielsen H, Pedersen O, Lindskow HO. Normalization of the insulin sensitivity and the cellular insulin binding during treatment of obese diabetics for one year. Acta Endocrinol 1979; 90: 103.
7. Scheen AJ, Paquot N, Castillo MJ et al. How to measure insulin action in vivo. Diabetes Metabolism Reviews 1994; 10: 151.
8. Norusis MJ. SPSS for Windows. Release G > O > Chicago: SPSS Inc., 1993.
9. Mcgarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 1980; 49: 395.
10. Rodrigues B, Xiang H, McNeill H. Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 1988; 37: 1358.
11. Bell FP, Raymond TL, Patnode CL. The influence of diet and carnitine supplementation on plasma carnitine, cholesterol and triglyceride in WHHL (Watanabo-heritable hyperlipidemic), Netherland dwarf and New Zealand rabbits (Dryctolagus cunniculus). Comp Biochem Physiol B 1987; 87: 587.
12. Seccombe DW, James L, Hahn P et al. L-carnitine treatment in the hyperlipidemic rabbit. Metabolism 1987; 36: 1192.
13. Rodrigues B, Ross JR, Farahbakshian S et al. Effects of in vivo and in vitro treatment with L-carnitine on isolated hearts from chronically diabetic rats. Can J Pharm 1990; 68: 1085.
14. Grundy SM, Mok HY, Zech L et al. Transport of very low density lipoprotein triglyceride in varying degrees of obesity and hypertriglyceridemia. J Clin Invest 1979; 63: 1274.
15. Frayan KM. Insulin resistance and lipid metabolism. Curr Opin Lipidol 1993; 4: 197.
16. Mondola P, Belfiore A, Santangelo F et al. The effect of L-carnitine on the apolipoprotein pattern of rats fed a cholesterol-rich diet. Comp Biochem Physiol B 1988; 89: 69.
17. Raymond TL, Reynold SA, Swanson JA et al. The effect of oral L-carnitine on lipoprotein composition in the Watanabe Heritable Hyperlipidemic Rabbit (Oryctolagus cuniculus). Comp Biochem Physiol A 1987; 88: 503.
18. Ferrannini E, Buzzigoli G, Bevilacqua S et al. Interaction of carnitine with insulin-stimulated glucose metabolisms in humans. Am J Physiol 1988; 255: E946.